XML 27 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents $ 6,092 $ 6,515
Short-term investments 2,406 7,826
Accounts receivable (net of allowance for doubtful accounts of $210 in 2017 and $195 in 2016) 6,873 7,018
Inventories (excludes inventories of $1,187 in 2017 and $1,117 in 2016 classified in Other assets - see Note 7) 5,096 4,866
Other current assets 4,299 4,389
Total current assets 24,766 30,614
Investments 12,125 11,416
Property, Plant and Equipment (at cost)    
Land 365 412
Buildings 11,726 11,439
Machinery, equipment and office furnishings 14,649 14,053
Construction in progress 2,301 1,871
Property, plant and equipment (at cost) 29,041 27,775
Less: accumulated depreciation 16,602 15,749
Property, plant and equipment, net 12,439 12,026
Goodwill 18,284 18,162
Other Intangibles, Net 14,183 17,305
Other Assets 6,075 5,854
Total Assets 87,872 95,377
Current Liabilities    
Loans payable and current portion of long-term debt 3,057 568
Trade accounts payable 3,102 2,807
Accrued and other current liabilities 10,427 10,274
Income taxes payable 708 2,239
Dividends payable 1,320 1,316
Total current liabilities 18,614 17,204
Long-Term Debt 21,353 24,274
Deferred Income Taxes 2,219 5,077
Other Noncurrent Liabilities 11,117 8,514
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016 1,788 1,788
Other paid-in capital 39,902 39,939
Retained earnings 41,350 44,133
Accumulated other comprehensive loss (4,910) (5,226)
Stockholders' equity before deduction for treasury stock 78,130 80,634
Less treasury stock, at cost: 880,491,914 shares in 2017 and 828,372,200 shares in 2016 43,794 40,546
Total Merck & Co., Inc. stockholders’ equity 34,336 40,088
Noncontrolling Interests 233 220
Total equity 34,569 40,308
Total Liabilities and Equity $ 87,872 $ 95,377